MYLAH MAHON-DAVENDA: Open Payments
NPI 1649615154 · NORTH ANDOVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$415 in 18 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $415
Food & beverage: $415
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $195 |
| GlaxoSmithKline, LLC. | 2 | $56 |
| Viatris Specialty LLC | 2 | $45 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| GENZYME CORPORATION | 1 | $31 |
| Verona Pharma, Inc. | 1 | $28 |
| Amgen Inc. | 1 | $22 |
Products named: FASENRA, TEZSPIRE, DUPIXENT, YUPELRI, TRELEGY ELLIPTA, AIRSUPRA, Ohtuvayre, NUCALA.
Industry payments across MA — which companies pay providers there.
